Early Prediction of Primary Non-Response to Infliximab in Crohn's Disease Using Routinely Available Clinical and Week 2 Laboratory Indicators: A Two-Center Real-World Cohort Study.

Zhao M, Zhao D, Geng L, Wang S, Wang B, Feng B

Open source

DOI
10.2147/jir.s627300
Published
2026
Container
Journal of inflammation research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/jir.s627300,
  title = {Early Prediction of Primary Non-Response to Infliximab in Crohn's Disease Using Routinely Available Clinical and Week 2 Laboratory Indicators: A Two-Center Real-World Cohort Study.},
  author = {Zhao M and Zhao D and Geng L and Wang S and Wang B and Feng B},
  year = {2026},
  journal = {Journal of inflammation research},
  doi = {10.2147/jir.s627300},
  url = {https://doi.org/10.2147/jir.s627300}
}

RIS

TY  - JOUR
TI  - Early Prediction of Primary Non-Response to Infliximab in Crohn's Disease Using Routinely Available Clinical and Week 2 Laboratory Indicators: A Two-Center Real-World Cohort Study.
AU  - Zhao M
AU  - Zhao D
AU  - Geng L
AU  - Wang S
AU  - Wang B
AU  - Feng B
PY  - 2026
JO  - Journal of inflammation research
DO  - 10.2147/jir.s627300
UR  - https://doi.org/10.2147/jir.s627300
ER  - 

APA

M, Z., D, Z., L, G., S, W., B, W., & B, F. (2026). Early Prediction of Primary Non-Response to Infliximab in Crohn's Disease Using Routinely Available Clinical and Week 2 Laboratory Indicators: A Two-Center Real-World Cohort Study.. Journal of inflammation research. https://doi.org/10.2147/jir.s627300

Source records